Johnson & Johnson: Company Report

One Johnson & Johnson Plaza
New Brunswick NJ 08933
http://www.jnj.com/

  • Phone: 732-5240400
  • Fax: 732-2140332

  • Industry : Drug Manufacturers - Major
  • Employees : 117,000
  • Exchange : NYSE

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has more than 250 operating companies. The Company operates in three segments. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women’s healthcare fields, as well as nutritional and over-the-counter pharmaceutical products. The Pharmaceutical segment includes products in the therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers. In July 2009, Johnson & Johnson completed the acquisition of Cougar Biotechnology, Inc. with approximately 95.9% interest in Cougar Biotechnology's outstanding common stock.

Stock Activity
fyi Last Price 62.76
52 Week High 65.95
52 Week Low 46.25
Volume 11.36 Mil
Average Daily Volume (13wk) 11.41 Mil
fyi 50 Day Moving Average 64.10
200 Day Moving Average 59.97
Volatility (beta) 0.56
Detailed quote

Financial data in U.S. dollars

Stock Price History
ChangeRelative Strength
fyi Last 3 Months 2.7% 65
Last 6 Months 2.7% 52
fyi Last 12 Months 6.6% 35
Historical charts
Institutional Statistics
Analyst ConsensusModerate Buy
Institutional Ownership62.60%
More Analyst Ratings

Want to learn how to evaluate a stock? Walk through the steps using the Research Wizard.

advertisement
Financials
Last 12 Months5 Year Growth
Sales 61.9 Bil 5.5%
Income 12.3 Bil 8.4%
Dividend Rate 1.96 12.00%
Dividend Yield 3.14% 2.50%
More financials
Fundamental Data
Debt/Equity RatioNA
Gross Margin70.20%
Net Profit Margin19.82%
Total Shares Outstanding2.8 Bil
Market Capitalization173.16 Bil
Earnings/Share4.40
StockScouter Rating7
More financial ratios
Earnings Estimates
Qtr(3/10) EPS Estimate 1.28
FY(12/10) EPS Estimate 4.92
Current P/E 14.20
FY(12/11) EPS Estimate 5.36
Forward P/E 11.71
Next Earnings Release: N/A
More analyst estimates
MSN Money
Search MSN Money
Message Boards
Site Status